Credent Connect N Care Limited · NSE:CREDENT
Credent Connect N Care — H1 FY27 Earnings Presentation
24 slides from Credent Connect N Care's earnings presentation, Oct 28, 2026
Slide 1: NSE filing cover letter for H1 FY27 earnings presentation
("3 CREDENT CONNECT/VCARE LTD. CREDENT (FORMERLY KNOWN AS CREDENT CONNECT N CARE PVT. LTD.) CIN : L63000DL2015PLC281994 AN ISI 9001:2015 Certified Company UDYAM -DL-03-0011706 October 28, 2026 To National Stock Exchange of India Limited Exchange Plaza. 5th Floor. Plot No. C-l. G Block, Bandra Kurla
Slide 2: Credent Connect N Care Ltd. Investor Presentation – H1FY27
Credent Connect N Care Ltd. Investor Presentation – H1FY27
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), has been prepared by Credent Connect N Care Ltd. (the “Company”), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not fo
Slide 4: Table of Contents
Table of Contents 01. Company Overview 02. Competitive Advantage Industry Opportunity: 03. A Growing Market for C3 Financial Highlights 04. H1FY27 05. Annual Financials 3
Slide 5: From the MD's Desk
From the MD's Desk As we reflect on H1FY27, our focus remains on building Credent Connect N Care Limited into an integrated healthcare logistics and pre-analytics platform. With over 14 years of experience, a pan-India network and strong healthcare relationships, we continue to strengthen our capabi
Slide 6: Company Overview
Company Overview 5
Slide 7: Credent | A Leading Integrated Healthcare Logistics Platform
Credent | A Leading Integrated Healthcare Logistics Platform Credent Connect N Care Limited is a market leader in the healthcare-focused operations and logistics industry, enabling the seamless movement of diagnostic samples, medical supplies and patient-facing healthcare services across India. With
Slide 8: From Cold Chain to Healthcare Logistics Platform
From Cold Chain to Healthcare Logistics Platform 2026 2025 Tech Platform Acquisition and Public Listing 2024 M&A Consolidation and Public Conversion Acquired Alltrak Technologies Rebranding and Workforce to own proprietary route Excellence Acquired ISO 9001:2015, 2022 - 2023 ISO 13485:2016 and ISO o
Slide 9: Management Team
Management Team Tarun Sharma Karan Sharma CA Sachin Sharma Promoter, Chairman & MD Promoter, Whole Time Director Chief Financial Officer Brings 14+ years of experience across Brings 9+ years of experience in Brings 14+ years of experience across healthcare logistics, cold-chain, healthcare logistics
Slide 10: Credent's End-to-End, Technology-Enabled Healthcare Logistics Workflow
Credent's End-to-End, Technology-Enabled Healthcare Logistics Workflow Home Sample Collection Patient-centric collection at home 01. 02. 03. 04. 05. > > Sample Home visit by trained Sample labelling Handover for Laboratory Booking & Phlebotomist Laboratory / Collection & phlebotomist and handover to
Slide 11: Competitive Advantage
Competitive Advantage 10
Slide 12: Why Healthcare Logistics is Different
Why Healthcare Logistics is Different Differentiating Healthcare Logistics from Conventional Logistics Time Temperature Chain of Compliance Last-Mile Technology Sensitivity Integrity Custody & Quality Complexity Integration Samples need to Certain samples and Samples require Healthcare logistics Lar
Slide 13: Nationwide Reach, Seamless Execution | Supporting Clients Across India
Nationwide Reach, Seamless Execution | Supporting Clients Across India Pan-India Coverage > Services available across all states and union territories. Client-Led Expansion > We scale with our clients’ growth plans, wherever they want to expand. Scalable Network Network Strength > Ability to rapidly
Slide 14: 2030 Roadmap for Growth & Value Creation
2030 Roadmap for Growth & Value Creation FY27 FY28 FY29 FY30 Strengthen the Foundation Platform Scaling & Integration Profitable Growth & Scale Expand with Discipline • Integrate acquired capabilities • Pursue selective organic and • Deepen relationships across the six • Evaluate international marke
Slide 15: Industry Opportunity: A Growing Market for C3
Industry Opportunity: A Growing Market for C3 14
Slide 16: C3 Well Positioned for the Growth of India's Diagnostic Ecosystem
C3 Well Positioned for the Growth of India's Diagnostic Ecosystem Structural Growth Drivers Supporting Demand for Specialised Healthcare Logistics Increasing Diagnostic Testing1 Expansion Beyond Metros4 US$11.8 Bn 397 District Labs India’s diagnostic services market is estimated at District Public H
Slide 17: Financial Highlights H1FY27
Financial Highlights H1FY27 16
Slide 18: Profit & Loss Highlights – H1FY27
Profit & Loss Highlights – H1FY27 Particulars (Rs Mn) H1FY27 H1FY26 YoY% FY26 FY25 YoY% Revenue from Operations 1,381 900 53% 2,142 818 162% Direct Overheads 480 298 733 277 Employee Expenses 536 355 846 272 Other Expenses 184 128 276 181 EBITDA 182 119 53% 287 88 226% EBITDA Margin (%) 13% 13% 13%
Slide 19: Annual Financials
Annual Financials 18
Slide 20: Strong Financial Performance
Strong Financial Performance Revenue from Operations (Rs Mn) EBITDA (Rs Mn) & Margin (%) PAT (Rs Mn) & Margin (%) 2,142 13% 13% 11% 1,381 11% 9% 7% 757 818 6% 287 4% 184 182 147 43 88 55 27 FY24 FY25 FY26 H1FY27 FY24 FY25 FY26 H1FY27 FY24 FY25 FY26 H1FY27* ROE & ROCE (%) Debt to Equity (x) 50% 44% 2
Slide 21: Profit and Loss Statement
Profit and Loss Statement Particulars (Rs Mn) FY24 FY25 FY26 H1FY27 Revenue from Operations 757 818 2,142 1,381 Direct Overheads 212 277 733 480 Employee Expenses 358 272 846 536 Other Expenses 144 181 276 184 EBITDA 43 88 287 182 EBITDA Margin (%) 6% 11% 13% 13% Depreciation 5 12 34 19 EBIT 38 76 2
Slide 22: Balance Sheet
Balance Sheet Equity & Liabilities (Rs Mn) Mar-24 Mar-25 Mar-26 Sept-26 Assets (Rs Mn) Mar-24 Mar-25 Mar-26 Sept-26 Equity 137 160 438 1,420 Total Non-Current Asset 17 75 146 171 Property, Plant & Equipment 16 65 73 78 Equity Share Capital 2 2 133 182 Intangible Assets 0 1 20 66 Reserves & Surplus 1
Slide 23: Cash Flow Statement
Cash Flow Statement Particulars (Rs Mn) Mar-24 Mar-25 Mar-26 Sept-26 (A) Net Cash Flow from Operating Activities 8 61 -66 -39 (B) Net Cash Flow from Investing Activities -11 -69 -108 -109 (C) Net Cash Flow from Financing Activities 22 -3 187 818 Net (Decrease)/ Increase in Cash & Cash Equivalents (A
Slide 24: Connect with Us
Connect with Us Credent Connect N Care Ltd. Stellar IR Advisors Pvt. Ltd. CA Sachin Sharma | Chief Financial Officer Suyash Samant | [email protected] [email protected] Jay Sangani | jay.stellar-ir.com +91 9811113190 022 62398024 www.C3Logistics.co.in www.stellar-ir.com
Credent Connect N Care — H1 FY27 Earnings Presentation on 6ix